Skip to main content
. 2015 Nov 25;3(1):3–10. doi: 10.1002/ehf2.12071

Figure 5.

Figure 5

Kaplan–Meier analysis of major adverse cardiovascular events in the full study sample and in participants with B‐type natriuretic peptide ≥50 pg/mL. (Reproduced with permission, ref 39).